Fiona P. Havers

8.9k total citations · 2 hit papers
63 papers, 2.0k citations indexed

About

Fiona P. Havers is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Fiona P. Havers has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 27 papers in Infectious Diseases and 10 papers in Microbiology. Recurrent topics in Fiona P. Havers's work include Influenza Virus Research Studies (30 papers), Respiratory viral infections research (25 papers) and Pneumonia and Respiratory Infections (14 papers). Fiona P. Havers is often cited by papers focused on Influenza Virus Research Studies (30 papers), Respiratory viral infections research (25 papers) and Pneumonia and Respiratory Infections (14 papers). Fiona P. Havers collaborates with scholars based in United States, China and Hong Kong. Fiona P. Havers's co-authors include H. Keipp Talbot, Lauren E. Roper, Michael Melgar, Amadea Britton, Camille N. Kotton, Sarah S. Long, Alicia M. Fry, Denise V. D’Angelo, Katherine E. Kahn and Steven Grinspoon and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

Fiona P. Havers

61 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

2023 172 citations Michael Melgar, Amadea Britton et al. MMWR Morbidity and Mortality Weekly Report profile →
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

2024 67 citations Amadea Britton, Lauren E. Roper et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fiona P. Havers United States	24	1.2k	720	408	226	193	63	2.0k
Stefano Tempia South Africa	32	2.6k 2.2×	1.0k 1.4×	421 1.0×	105 0.5×	158 0.8×	166	3.4k
Justin R. Ortiz United States	31	2.6k 2.2×	663 0.9×	1.0k 2.5×	102 0.5×	233 1.2×	119	3.3k
Leslie Z. Sokolow United States	16	2.5k 2.1×	658 0.9×	942 2.3×	77 0.3×	150 0.8×	22	3.1k
Lenee Blanton United States	24	1.6k 1.3×	845 1.2×	458 1.1×	44 0.2×	113 0.6×	36	2.3k
Hannah C. Moore Australia	31	2.0k 1.7×	643 0.9×	308 0.8×	230 1.0×	254 1.3×	155	2.9k
Jim McMenamin United Kingdom	34	2.3k 1.9×	1.6k 2.2×	755 1.9×	82 0.4×	164 0.8×	109	4.0k
Scott A. Harper United States	14	2.5k 2.1×	1.1k 1.5×	266 0.7×	124 0.5×	237 1.2×	19	3.2k
Sibongile Walaza South Africa	27	1.8k 1.5×	807 1.1×	316 0.8×	60 0.3×	57 0.3×	114	2.3k
Kristen A. Feemster United States	26	1.2k 1.0×	485 0.7×	1.1k 2.8×	84 0.4×	121 0.6×	113	2.2k
Tyra Grove Krause Denmark	28	1.1k 0.9×	847 1.2×	648 1.6×	30 0.1×	126 0.7×	100	2.5k

Countries citing papers authored by Fiona P. Havers

Since Specialization

Citations

This map shows the geographic impact of Fiona P. Havers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona P. Havers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona P. Havers more than expected).

Fields of papers citing papers by Fiona P. Havers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona P. Havers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona P. Havers. The network helps show where Fiona P. Havers may publish in the future.

Co-authorship network of co-authors of Fiona P. Havers

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona P. Havers. A scholar is included among the top collaborators of Fiona P. Havers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona P. Havers. Fiona P. Havers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiegand, Ryan E., Owen Devine, Megan J. Wallace, et al.. (2025). Estimating COVID-19 associated hospitalizations, ICU admissions, and in-hospital deaths averted in the United States by 2023–2024 COVID-19 vaccination: A conditional probability, causal inference, and multiplier-based approach. Vaccine. 49. 126808–126808. 1 indexed citations

Berry, Isha, Benjamin J. Silk, Fiona P. Havers, et al.. (2024). SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023. PLoS ONE. 19(12). e0311488–e0311488. 1 indexed citations

Hutton, David W., Lisa A. Prosser, Angela M. Rose, et al.. (2024). Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus. Vaccine. 42(24). 126294–126294. 9 indexed citations

Panagiotakopoulos, Lakshmi, Danielle Moulia, Monica Godfrey, et al.. (2024). Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025. MMWR Morbidity and Mortality Weekly Report. 73(37). 819–824. 29 indexed citations

Taylor, Christopher A., Michael Whitaker, Monica E. Patton, et al.. (2024). Trends in COVID‐19–Attributable Hospitalizations Among Adults With Laboratory‐Confirmed SARS‐CoV‐2—COVID‐NET, June 2020 to September 2023. Influenza and Other Respiratory Viruses. 18(11). e70021–e70021. 1 indexed citations

Wallace, Megan, Hannah G. Rosenblum, Danielle Moulia, et al.. (2023). A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States. Vaccine. 41(44). 6456–6467. 11 indexed citations

Shah, Melisa M., Kadam Patel, Jennifer Milucky, et al.. (2023). Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022. Influenza and Other Respiratory Viruses. 17(3). e13107–e13107. 16 indexed citations

Wei, Stanley C., Kristie E.N. Clarke, Miriam E. Van Dyke, et al.. (2023). Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods: September 2020–November 2021. The Journal of Infectious Diseases. 229(1). 122–132. 5 indexed citations

Woodruff, Rebecca C., Michael Melgar, Huong Pham, et al.. (2023). Abstract 11882: Acute Cardiac Events Among Older Adults Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus. Circulation. 148(Suppl_1).

10.

Kenmoe, Sébastien, Helen Y. Chu, Fatimah S. Dawood, et al.. (2023). Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections during Pregnancy. SSRN Electronic Journal. 1 indexed citations

11.

O’Halloran, Alissa, Michael Whitaker, Kadam Patel, et al.. (2023). Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–2021. Influenza and Other Respiratory Viruses. 17(1). e13089–e13089. 5 indexed citations

12.

Melgar, Michael, Amadea Britton, Lauren E. Roper, et al.. (2023). Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(29). 793–801. 172 indexed citations breakdown →

13.

Rose, Erica Billig, Rebecca M. Dahl, Fiona P. Havers, Georgina Peacock, & Gayle Langley. (2021). Respiratory Syncytial Virus-Associated Hospitalizations in Children With Neurological Disorders, 2006–2015. Journal of the Pediatric Infectious Diseases Society. 10(10). 951–957. 4 indexed citations

14.

Thompson, Mark G., Benjamin J. Cowling, A. Danielle Iuliano, et al.. (2020). Comparison of alternative full and brief versions of functional status scales among older adults in China. PLoS ONE. 15(8). e0234698–e0234698. 2 indexed citations

15.

Razzaghi, Hilda, Katherine E. Kahn, Carla L. Black, et al.. (2020). Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020. MMWR Morbidity and Mortality Weekly Report. 69(39). 1391–1397. 121 indexed citations

16.

Kahn, Katherine E., Carla L. Black, Helen Ding, et al.. (2018). Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018. MMWR Morbidity and Mortality Weekly Report. 67(38). 1055–1059. 100 indexed citations

17.

Havers, Fiona P., Alicia M. Fry, Jufu Chen, et al.. (2015). Hospitalizations Attributable to Respiratory Infections among Children with Neurologic Disorders. The Journal of Pediatrics. 170. 135–141.e5. 26 indexed citations

18.

Xu, Cuiling, Fiona P. Havers, Lijie Wang, et al.. (2013). Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, China. Emerging infectious diseases. 19(8). 1289–92. 76 indexed citations

19.

Havers, Fiona P., Lijie Wang, Tao Chen, et al.. (2013). Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, China. Emerging infectious diseases. 19(8). 3 indexed citations

20.

Appiah, Lambert, et al.. (2009). Efficacy and Acceptability of Rapid, Point-of-Care HIV Testing in Two Clinical Settings in Ghana. AIDS Patient Care and STDs. 23(5). 365–369. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact